• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四环素类:具有巨大治疗潜力的药物。

Tetracyclines: drugs with huge therapeutic potential.

机构信息

University of New South Wales Department of Surgery, St George Hospital, Sydney, Australia.

出版信息

Mini Rev Med Chem. 2012 Jan;12(1):44-52. doi: 10.2174/138955712798868977.

DOI:10.2174/138955712798868977
PMID:22070692
Abstract

Tetracyclines are an amazing class of chemical agents with multiple therapeutic potential. Structural modification of the original natural tetracyclines led to the synthesis and development of doxycycline and minocycline, compounds with higher lipophilicity, better oral pharmacokinetics and higher potency. Due to diverse pharmacological properties, these drugs are now under extensive investigation for use in the treatment of various disparate diseases. In recent years, several studies have conclusively reported anti-inflammatory, immune-modulating and neuroprotective effects of these compounds. There are currently over 200 ongoing clinical trials on tetracyclines. These studies extend over a wide range of diseases including dermatological diseases, behavior and mental disorders, immune system disorders, cardiovascular diseases, and cancer. In this review we will discuss the chemistry and pharmacology of these agents, and describe how their inhibitory effect on matrix metalloproteinase and on pro-inflammatory cytokines has kindled renewed interest in them. Based on the reports from pre-clinical and clinical trials, the therapeutic potential and application of tetracyclines may well be redefined and extensively extended.

摘要

四环素类是一类具有多种治疗潜力的神奇化学药物。对原始天然四环素进行结构修饰,导致了强力霉素和二甲胺四环素的合成和发展,这些化合物具有更高的亲脂性、更好的口服药代动力学和更高的效力。由于具有多种药理学特性,这些药物目前正在广泛研究用于治疗各种不同的疾病。近年来,有几项研究明确报告了这些化合物的抗炎、免疫调节和神经保护作用。目前有超过 200 项关于四环素的临床试验正在进行。这些研究涵盖了广泛的疾病,包括皮肤病、行为和精神障碍、免疫系统疾病、心血管疾病和癌症。在这篇综述中,我们将讨论这些药物的化学和药理学,并描述它们对基质金属蛋白酶和促炎细胞因子的抑制作用如何重新引起人们的兴趣。基于临床前和临床试验的报告,四环素的治疗潜力和应用可能会被重新定义和广泛扩展。

相似文献

1
Tetracyclines: drugs with huge therapeutic potential.四环素类:具有巨大治疗潜力的药物。
Mini Rev Med Chem. 2012 Jan;12(1):44-52. doi: 10.2174/138955712798868977.
2
Tetracycline repurposing in neurodegeneration: focus on Parkinson's disease.四环素在神经退行性疾病中的再利用:聚焦帕金森病。
J Neural Transm (Vienna). 2018 Oct;125(10):1403-1415. doi: 10.1007/s00702-018-1913-1. Epub 2018 Aug 14.
3
Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature.四环类抗生素:一类具有广阔治疗前景的多功能化合物家族。文献综述。
Am J Physiol Cell Physiol. 2010 Sep;299(3):C539-48. doi: 10.1152/ajpcell.00047.2010. Epub 2010 Jun 30.
4
Doxycycline and other tetracyclines in the treatment of bone metastasis.强力霉素及其他四环素类药物在骨转移治疗中的应用
Anticancer Drugs. 2003 Nov;14(10):773-8. doi: 10.1097/00001813-200311000-00001.
5
Non-antibiotic properties of tetracyclines and their clinical application in dermatology.四环素的非抗生素特性及其在皮肤科的临床应用
Australas J Dermatol. 2014 May;55(2):111-8. doi: 10.1111/ajd.12075. Epub 2013 Jun 28.
6
An update on tetracyclines.四环素类药物的最新进展。
Curr Opin Investig Drugs. 2006 Feb;7(2):167-71.
7
Neuroprotection by tetracyclines.四环素的神经保护作用。
Trends Pharmacol Sci. 2004 Dec;25(12):609-12. doi: 10.1016/j.tips.2004.10.001.
8
Tetracyclines: nonantibiotic properties and their clinical implications.四环素类:非抗生素特性及其临床意义。
J Am Acad Dermatol. 2006 Feb;54(2):258-65. doi: 10.1016/j.jaad.2005.10.004.
9
Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: a mechanistic link between local and systemic inflammation.非抗菌型四环素类药物调节牙周炎和动脉粥样硬化性心血管疾病的介质:局部和全身炎症之间的机制联系。
Pharmacol Res. 2011 Dec;64(6):573-9. doi: 10.1016/j.phrs.2011.06.023. Epub 2011 Jul 13.
10
Antimicrobial and non-antimicrobial tetracyclines in human cancer trials.人用癌症试验中的抗菌和非抗菌四环素类药物。
Pharmacol Res. 2011 Feb;63(2):151-6. doi: 10.1016/j.phrs.2010.10.008. Epub 2010 Oct 15.

引用本文的文献

1
Oral tetracyclines for bone and joint infections: what do we know?用于骨与关节感染的口服四环素类药物:我们了解些什么?
J Bone Jt Infect. 2025 Apr 8;10(2):143-154. doi: 10.5194/jbji-10-143-2025. eCollection 2025.
2
C10-Benzoate Esters of Anhydrotetracycline Inhibit Tetracycline Destructases and Recover Tetracycline Antibacterial Activity.脱水四环素的C10 - 苯甲酸酯抑制四环素破坏酶并恢复四环素抗菌活性。
ACS Infect Dis. 2025 Mar 14;11(3):738-749. doi: 10.1021/acsinfecdis.4c00912. Epub 2025 Feb 6.
3
Advancements in Imaging and Therapeutic Options for Dry Age-Related Macular Degeneration and Geographic Atrophy.
干性年龄相关性黄斑变性和地图样萎缩的成像与治疗选择进展
Ophthalmol Ther. 2024 Aug;13(8):2067-2082. doi: 10.1007/s40123-024-00970-7. Epub 2024 Jun 4.
4
Minocycline and photodynamic priming significantly improve chemotherapy efficacy in heterotypic spheroids of pancreatic ductal adenocarcinoma.米诺环素和光动力预处理显著提高胰腺导管腺癌异质球体的化疗疗效。
J Photochem Photobiol B. 2024 Jun;255:112910. doi: 10.1016/j.jphotobiol.2024.112910. Epub 2024 Apr 16.
5
Emerging Medical Therapies in Rosacea: A Narrative Review.酒渣鼻的新兴医学疗法:一项叙述性综述
Dermatol Ther (Heidelb). 2023 Dec;13(12):2933-2949. doi: 10.1007/s13555-023-01048-1. Epub 2023 Oct 12.
6
Silymarin enhances the response to oxytetracycline treatment in Oreochromis niloticus experimentally infected with Aeromonas hydrophila.水飞蓟素增强了实验感染嗜水气单胞菌的尼罗罗非鱼对土霉素治疗的反应。
Sci Rep. 2023 Sep 27;13(1):16235. doi: 10.1038/s41598-023-43270-z.
7
Structure-Based Design of Bisubstrate Tetracycline Destructase Inhibitors That Block Flavin Redox Cycling.基于结构的双底物四环素破坏酶抑制剂设计,阻断黄素氧化还原循环。
J Med Chem. 2023 Mar 23;66(6):3917-3933. doi: 10.1021/acs.jmedchem.2c01629. Epub 2023 Mar 6.
8
Crystal structure determination of the halogenase CtcP from Streptomyces aureofaciens.链霉菌属 Aureofaciens 卤酶 CtcP 的晶体结构测定。
Acta Crystallogr F Struct Biol Commun. 2022 Jul 1;78(Pt 7):270-275. doi: 10.1107/S2053230X22006586. Epub 2022 Jul 4.
9
Tetracyclines-An Important Therapeutic Tool for Dermatologists.四环素类——皮肤科医生的重要治疗工具。
Int J Environ Res Public Health. 2022 Jun 13;19(12):7246. doi: 10.3390/ijerph19127246.
10
Piperacillin/Tazobactam and Meropenem Use Increases the Risks for Acute Graft Rejection Following First Kidney Transplantation.哌拉西林/他唑巴坦和美罗培南的使用会增加首次肾移植后急性移植物排斥反应的风险。
J Clin Med. 2022 May 11;11(10):2726. doi: 10.3390/jcm11102726.